Procter & Gamble's Trading Volume Drops 30% Placing 96th in Daily Market Rankings

On June 18, 2025, The's trading volume reached 7.54 billion, marking a 30.18% decrease from the previous day, placing it at the 96th position in the daily market rankings. The stock price of The has declined by 0.32% over the past two days, resulting in a total decrease of 1.78%.

The Procter & Gamble Company (The) is a key player in the health and beauty sectors, driven by its innovative products and corporate social responsibility initiatives aimed at global well-being. The company's products, ranging from health and hygiene to cleaning, are essential to daily consumer routines worldwide. The management at The sees significant opportunities in power oral care, with the launch of iO2 aimed at converting manual toothbrush users to electric toothbrushes, presenting a $5 billion growth opportunity. The company is committed to innovation and job creation, even amidst short-term market volatility, to safeguard long-term investments in brand equity, innovation, and demand creation.

In the beauty sector, The is focused on skin care and specialty beauty, continuously innovating its beauty portfolio for super-premium offerings, strengthening its department store presence, and investing in beauty counselors. The company's brands, including Head & Shoulders, Pantene, and Rejoice, are central to its strategy. In the third quarter of fiscal 2025, the Beauty segment, which accounted for around 18% of quarterly sales, saw a 2% year-over-year increase in organic sales. Hair Care organic sales remained flat due to higher pricing in Latin America and North America, offset by lower volumes in Greater China. Personal Care organic sales grew by high single digits, driven by innovation-led volume growth, while Skin Care organic sales decreased by low single digits due to soft volumes and an unfavorable geographic mix.

The Health Care segment, which made up roughly 15% of the fiscal third quarter, posted a 4% organic sales increase. Oral care organic sales improved by low single digits due to premium innovation, while Personal Health Care organic sales increased by high single digits, driven by solid volumes and higher pricing, particularly in Latin America and Europe. The company expects a 2% year-over-year increase in organic sales for the Beauty segment and a 5% increase for the Health Care segment in the fourth quarter of fiscal 2025. The company's focus on superior-quality assortments across its health and beauty portfolio, along with community support programs, is expected to drive sustained growth and profitability.